fda tirzepatide ruling Compounders lose battle over Eli Lilly weight loss drug and shortage list GLP-1 Drugs: Brand Companies Push

Tirzepatide dual GIP/GLP-1 mechanism produces greater average weight loss (22.5% vs 15% to 17% for semaglutide in comparable trials) but also tends to cause more gastrointestinal side effects, particularly at higher doses

MEDVi also outsources clinical care to OpenLoop Health, which disclosed a January 2026 data breach affecting approximately 1.6 million patient records (68,160 confirmed in Texas)

are less likely to use the drugs than white people, a 2024 study in the Journal of Racial and Ethnic Health Disparitie s found

Some of the most common side effects include: Additionally, if you take oral birth control pills, talk to your healthcare provider before you use Compounded Tirzepatide

If you have been diagnosed with NAION or another eye problem after taking Wegovy, you may be eligible to take legal action

GLP-1 market volume expansion